‘What are we supposed to do? Wait two weeks for a prescription for Sudafed?’: Brits react to news the drug could be withdrawn from UK shelves or sold only on prescription due to links to rare brain disorders
The Brits reacted after it was revealed that Sudafed could be withdrawn from UK shelves or even on prescription due to links to extremely rare but deadly brain disorders.
Medical regulators are “reviewing the available evidence” to see if the rules on the sale of pseudoephedrine should change, news broke yesterday.
‘Can’t this be serious? What are we supposed to do? Wait two weeks for a GP appointment for a prescription? One tweeted.
Another wrote: ‘Is it just the tablets or also the spray? I never run out of #Sudafed nasal spray, I have one on my nightstand right now.’
Health chiefs are spooked by reports of patients affected by two rare diseases. Both can cause strokes.
Other decongestants, such as products made by Benylin, Nurofen, and Day & Night Nurse, would also be affected if any changes were necessary.


Reaction on social media after news broke that medical regulators are “reviewing the available evidence” to see if the rules on the sale of pseudoephedrine need to be changed.

The Medicines and Healthcare Products Regulatory Agency (MHRA), which oversees the safety of medicines used in Britain, is behind the review.
Dozens of own-brand remedies, including those from Boots and Lloyds, also contain the chemical.
It works by narrowing the inflamed blood vessels in the sinuses, which is causing the nose to become blocked in the first place.
The Medicines and Healthcare Products Regulatory Agency (MHRA), which oversees the safety of medicines used in Britain, is behind the review.
A spokesperson told MailOnline: ‘We will provide further advice as appropriate. If people have concerns, they should talk to their pharmacist or doctor.’